アラシ ヒロユキ   ARASHI Hiroyuki
  嵐 弘之
   所属   医学部 医学科(東京女子医科大学病院)
   職種   助教
言語種別 日本語
発表タイトル Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndromes―From Multicenter Cohort Study―
会議名 第79回日本循環器学会学術集会
主催者 日本循環器学会
学会区分 全国規模の学会
発表形式 ポスター掲示
講演区分 一般
発表者・共同発表者◎岩朝薫, 大槻尚男, 渡邉真広, 神島一帆, 中尾優, 岡山大, 春木伸太郎, 重城健太郎, 嵐弘之, 南雄一郎, 高木厚, 太田吉実, 森文章, 藤井真也, 本田淳, 山口淳一, 萩原誠久
発表年月日 2015/04/24
開催地
(都市, 国名)
大阪市
概要 Background: Atrial fibrillation (AF) and acute coronary syndrome (ACS) require multiple antithrombotic agents. The aim of this study is to assess compare the clinical outcome between triple therapy (TT; warfarin + dual anti-platelet therapy [DAPT]) and DAPT.Methods and Results: Consecutive 450 patients with AF undergoing PCI were enrolled at 8 medical centers. Among them 164 patients (36%) presented with ACS. 88(54%) patients on TT and 77(46%) patients on DAPT at the time of PCI. Drug eluting stent was used in 94(57%). The incidence of major adverse cerebro-cardiovascular events (MACCE; cardiac death, non-fatal MI, stroke) and bleeding complications were evaluated. Results are shown below.Conclusion: TT group had higher CHADS2 and HAS-BLED score. The incidence of MACCE was equal but bleeding complications tended to be frequent in TT group.